Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
VANDA PHARMA Add to My Watchlist (NSDQ: VNDA) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Vanda 10.60 +0.40 (+3.92%) 269,352
9605 Medical Center Drive
Suite 300
Rockville, MD 20850 US
(240) 599-4500
(301) 294-1900 fax
www.vandapharmaceuticals.com
CEO Dr. Mihael Hristos Polymeropoulos
Auditor PRICEWATERHOUSECOOPERS LLP
Exchange Traded NQ
ISIN Number US9216591084
CIK Number 1347178
NAICS Code 325412
Business Summary
A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders, with exclusive worldwide commercial rights to two product candidates in clinical development.
Number of Employees 21
Share Fundamentals
Market Cap 288.34M
Shares Outstanding 27.20M
Float 15.99M
Short Interest 3.52M
Financial Strength
Revenue (TTM) N/A
Earnings (TTM) -$34,125,469
Quick Ratio 2.5:1
Current Ratio 3:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs